100 related articles for article (PubMed ID: 10692251)
1. The roles of the cyclo-oxygenases types one and two in prostaglandin synthesis in human fetal membranes at term.
Sawdy RJ; Slater DM; Dennes WJ; Sullivan MH; Bennett PR
Placenta; 2000 Jan; 21(1):54-7. PubMed ID: 10692251
[TBL] [Abstract][Full Text] [Related]
2. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
3. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.
Beubler E; Schuligoi R; Chopra AK; Ribardo DA; Peskar BA
J Pharmacol Exp Ther; 2001 Jun; 297(3):940-5. PubMed ID: 11356914
[TBL] [Abstract][Full Text] [Related]
4. Cyclo-oxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-D-aspartate receptors in rat hippocampus.
Pepicelli O; Fedele E; Berardi M; Raiteri M; Levi G; Greco A; Ajmone-Cat MA; Minghetti L
J Neurochem; 2005 Jun; 93(6):1561-7. PubMed ID: 15935072
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
6. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
9. Effect of selective vs. non-selective cyclo-oxygenase inhibitors on fetal membrane prostaglandin synthesis.
Sawdy R; Pan H; Sullivan M; Bennett P
J Obstet Gynaecol; 2003 May; 23(3):239-43. PubMed ID: 12850850
[TBL] [Abstract][Full Text] [Related]
10. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway.
Jiang XH; Lam SK; Lin MC; Jiang SH; Kung HF; Slosberg ED; Soh JW; Weinstein IB; Wong BC
Oncogene; 2002 Sep; 21(39):6113-22. PubMed ID: 12203123
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
[TBL] [Abstract][Full Text] [Related]
13. Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain.
Zhang YH; Lu J; Elmquist JK; Saper CB
J Comp Neurol; 2003 Aug; 463(1):3-12. PubMed ID: 12811798
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy.
Slater D; Dennes W; Sawdy R; Allport V; Bennett P
J Mol Endocrinol; 1999 Apr; 22(2):125-30. PubMed ID: 10194515
[TBL] [Abstract][Full Text] [Related]
15. COX-1 and COX-2 inhibitors.
Hawkey CJ
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):801-20. PubMed ID: 11566042
[TBL] [Abstract][Full Text] [Related]
16. Role of constitutive cyclooxygenase-2 in prostaglandin-dependent secretion in mouse colon in vitro.
MacNaughton WK; Cushing K
J Pharmacol Exp Ther; 2000 May; 293(2):539-44. PubMed ID: 10773026
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclooxygenase-2 decreases DNA synthesis induced by platelet-derived growth factor in Swiss 3T3 fibroblasts.
Castaño E; Bartrons R; Gil J
J Pharmacol Exp Ther; 2000 May; 293(2):509-13. PubMed ID: 10773022
[TBL] [Abstract][Full Text] [Related]
18. An inhibitor of type-1 cyclo-oxygenase in tissues from human pregnancy.
Willix-Payne DJ; Sun MY; Elder MG; Bennett PR; Sullivan MH
Acta Obstet Gynecol Scand; 1999 May; 78(5):403-7. PubMed ID: 10326885
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
Belton OA; Duffy A; Toomey S; Fitzgerald DJ
Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils.
Kimura T; Iwase M; Kondo G; Watanabe H; Ohashi M; Ito D; Nagumo M
Int Immunopharmacol; 2003 Oct; 3(10-11):1519-28. PubMed ID: 12946449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]